Former NFL edge rusher Randy Gregory, known for his stints with the Dallas Cowboys and Denver Broncos, has filed a lawsuit against the NFL and the Broncos, claiming “unjust fines” totaling $532,500.
Gregory’s legal action, reported by Chris Tomasson of The Denver Gazette, was lodged in Arapahoe County, Colorado, and centers on fines related to his use of a prescribed medication containing THC.
Gregory asserts that he was prescribed Dronabinol, a synthetic form of tetrahydrocannabinol (THC) that is FDA-approved, to treat social anxiety and post-traumatic stress disorders.
His lawsuit contends that the fines imposed for testing positive for THC are discriminatory, considering his medical condition and the legal status of marijuana in Colorado.
Gregory’s agent, Peter Schaffer, emphasized that the issue is primarily with the NFL’s policies, rather than the Broncos’ organization. Schaffer pointed out the contradiction between Gregory’s legal prescription and the fines, arguing that Gregory should receive reasonable accommodation for his disabilities as directed by his physician.
MORE: CeeDee Lamb Holds Off Commitment, Eyes NFC Rivals’ Moves
Gregory’s career in the NFL has been marked by both notable performances and several suspensions due to violations of the league’s substance-abuse policy. Since being drafted by the Cowboys in 2015, Gregory has accumulated 69 quarterback hits, 27 tackles for loss, 22 sacks, 10 forced fumbles, 3 pass deflections, 2 fumble recoveries, and 1 interception in 72 games.
However, he missed the 2017 and 2019 seasons due to suspensions and has been candid about his struggles with mental health, including social anxiety disorder.
In October 2023, the Broncos traded Gregory to the San Francisco 49ers, where he finished the season. Subsequently, he signed a one-year contract with the Tampa Bay Buccaneers in April 2024. Gregory’s current lawsuit seeks not only reimbursement for the fines but also protection from future penalties related to his use of THC-based medication.
Gregory’s case raises significant questions about the NFL’s substance-abuse policy and its alignment with state laws and medical prescriptions.
As the lawsuit progresses, it may prompt a broader discussion about accommodating players’ medical needs within the framework of league regulations.
